These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32769096)

  • 21. Metabolic acidosis is associated with pulse wave velocity in chronic kidney disease: Results from the KNOW-CKD Study.
    Kim HJ; Kang E; Ryu H; Han M; Lee KB; Kim YS; Sung S; Ahn C; Oh KH
    Sci Rep; 2019 Nov; 9(1):16139. PubMed ID: 31695082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metabolic complications of chronic kidney disease].
    Chazot C; Jean G; Joly D
    Nephrol Ther; 2017 Jun; 13(6S):6S30-6S36. PubMed ID: 29463397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D.
    Beaubien-Souligny W; Bezzaoucha S; Pichette V; Lafrance JP; Bell R; Lamarche C; Ouimet D; Vallee M
    Int Urol Nephrol; 2015 Jul; 47(7):1165-71. PubMed ID: 25982583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?
    Căpuşă C; Ştefan G; Stancu S; Lipan M; Tsur LD; Mircescu G
    Medicine (Baltimore); 2017 Nov; 96(47):e8802. PubMed ID: 29381982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.
    Quiñones H; Hamdi T; Sakhaee K; Pasch A; Moe OW; Pak CYC
    J Nephrol; 2019 Feb; 32(1):93-100. PubMed ID: 30465137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acid retention in chronic kidney disease is inversely related to GFR.
    Goraya N; Simoni J; Sager LN; Pruszynski J; Wesson DE
    Am J Physiol Renal Physiol; 2018 May; 314(5):F985-F991. PubMed ID: 29357423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of Acid-Base Derangements in CKD.
    Chen W; Abramowitz MK
    Adv Chronic Kidney Dis; 2017 Sep; 24(5):280-288. PubMed ID: 29031354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
    Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
    J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. It Is Really Time for Ammonium Measurement.
    Raphael KL; Yee J
    Adv Chronic Kidney Dis; 2018 Jul; 25(4):297-300. PubMed ID: 30139456
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of metabolic acidosis in patients with chronic kidney disease (CKD)].
    Dębowska M; Przedlacki J
    Wiad Lek; 2017; 70(6 pt 2):1197-1200. PubMed ID: 29533913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of allopurinol on metabolic acidosis and endothelial functions in chronic kidney disease patients.
    Bayram D; Tuğrul Sezer M; İnal S; Altuntaş A; Kıdır V; Orhan H
    Clin Exp Nephrol; 2015 Jun; 19(3):443-9. PubMed ID: 25082656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Acidosis in CKD: Core Curriculum 2019.
    Raphael KL
    Am J Kidney Dis; 2019 Aug; 74(2):263-275. PubMed ID: 31036389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of metabolic acidosis on QT intervals in patients with chronic kidney disease.
    Yenigun EC; Aypak C; Turgut D; Aydin MZ; Dede F
    Int J Artif Organs; 2016 Aug; 39(6):272-6. PubMed ID: 27515860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dietary acid load: A novel target for the nephrologist?].
    Chauveau P; Lasseur C; Nodimar C; Prezelin-Reydit M; Trolonge S; Combe C; Aparicio M
    Nephrol Ther; 2018 Jun; 14(4):240-246. PubMed ID: 29289517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The choice of dialysate bicarbonate: do different concentrations make a difference?
    Basile C; Rossi L; Lomonte C
    Kidney Int; 2016 May; 89(5):1008-1015. PubMed ID: 26924048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low serum bicarbonate and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Driver TH; Shlipak MG; Katz R; Goldenstein L; Sarnak MJ; Hoofnagle AN; Siscovick DS; Kestenbaum B; de Boer IH; Ix JH
    Am J Kidney Dis; 2014 Oct; 64(4):534-41. PubMed ID: 24953891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
    Bushinsky DA
    Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.